期刊文献+

肺动脉高压大鼠骨髓内皮祖细胞功能的研究 被引量:2

Function of bone marrow endothelial progenitor cell in rat model with pulmonary hypertension
下载PDF
导出
摘要 目的检测实验性肺动脉高压大鼠骨髓内皮祖细胞(EPC)的功能,探讨肺动脉高压发病机制。方法利用野百合碱诱导大鼠发生肺动脉高压,分离骨髓单个核细胞进行体外诱导培养以获得EPC集落,并对其骨髓内皮祖细胞的集落形成能力、增殖、黏附、迁移能力进行检测。结果骨髓单个核细胞在体外培养下能够获得EPC集落,与对照组比较,肺动脉高压实验组诱导生成的EPC数量少(P<0.05),CD34和FLK-1阴性比例下降(分别为19.33%±3.27%vs 31.17%±4.40%和33.67%±3.50%vs 44.50%±3.78%,P均<0.01),细胞增殖能力下降(0.43±0.08 vs 0.64±0.07,P<0.01),贴壁细胞减少(6.835个±1.605个vs 10.175个±1.945个,P<0.01),细胞迁移能力下降(7.83个±1.94个vs 11.83个±2.48个,P<0.05)。结论肺动脉高压的发生与骨髓内皮祖细胞功能的异常存在明显的相关性。 Objective To assess the function of bone marrow derived endothelial progenitor cell(EPC) with pulmonary hypertension in experimental rat model,and investigate the pathogenesis of pulmonary hypertension.Methods The rats were injected with crotaiine to induce pulmonary hypertension,then separate bone marrow mononuclear cell and cultured in vitro to obtain EPC colony.The ability of EPC colony forming,proliferate,adhesion and migration were assessed.Results EPC colony could be attained from bone marrow mononuclear cell in vitro.Compared with control group,the amount of EPC induced in experimental group was less(P0.05),the negative proportion of CD34 and FLK-1 was lowered(19.33%±3.27%vs 31.14%±4.40%and 33.67%±3.50%vs 44.50%±3.78%respectively,P0.01 ),the proliferate ability decreased(0.43±0.08 vs 0.64±0.07,P0.01 ),adherent cells decreased(6.835±1.605 vs 10.175±1.945,P0.01 ),migration ability weakened(7.83±1.94 vs 11.83±2.48,P0.05).Conclusion The incidence of pulmonary hypertension was associated with abnormal function of bone marrow endothelial progenitor evidently.
出处 《疑难病杂志》 CAS 2010年第11期825-827,F0003,共4页 Chinese Journal of Difficult and Complicated Cases
关键词 肺动脉高压 内皮祖细胞 骨髓 大鼠 Pulmonary hypertension Endothelial progenitor cell Bone marrow Rats
  • 相关文献

参考文献1

二级参考文献30

  • 1Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M,et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization.Nat Med 1999; 5: 434-8.
  • 2Aahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T,et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-7.
  • 3Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D,Wang J, et al. Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.Nat Med 2001: 7: 430-6.
  • 4Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S,Masuda H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001; 103: 634-7.
  • 5Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003;107: 461-8.
  • 6Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al. Therapeutic angiogenesis using cell transplantation (TACT) study investigators. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial. Lancet 2002; 360: 427-35.
  • 7Asmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI).Circulation 2002; 106:3009-17.
  • 8Pu LQ, Jackson S, Lachapelle KJ, Arekat Z, Graham AM, LisbonaR, et al. A persistent hindlimb ischemia model in the rabbit. J Invest Surg 1994; 7: 49-60.
  • 9Fan CL, Li Y, Gao PJ, Liu J J, Zhang X J, Zhu DL. Differentiation of endothelial progenitor cells from human umbilical cord bloodCD 34^+ cells in vitro. Acta Pharmacol Sin 2003; 24: 212-8.
  • 10Ito WD, Arras M, Scholz D, Winkler B, Htun P, Schaper W.Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol 1997; 273: H1255-65.

共引文献18

同被引文献25

  • 1孔敬博,祁学文,刘海峰,孔祥泉,杨传胜.冠心病患者循环内皮祖细胞与基质细胞衍生因子-1α的变化[J].疑难病杂志,2007,6(7):385-388. 被引量:3
  • 2林杰,张怀勤.内皮祖细胞治疗冠脉粥样硬化前景[J].中国全科医学,2007,10(17):1466-1469. 被引量:5
  • 3魏来,赵强,陈安清,陆军,姚瑞明,贾剑国,王克强,邹云增.右侧全肺切除致大鼠动力型肺动脉高压模型的建立[J].中国临床医学,2007,14(4):482-484. 被引量:5
  • 4Stenmark KR, McMurtry IF. Vascular remodeling versus vasoconstriction in chronic hypoxic pulmonary hypertension: a time for reappraisal?. Circ Res, 2005,97(2) :95-98.
  • 5Okada K, Tanaka Y, Bernstein M, et al. Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol, 1997,151 (4) :1019-1025.
  • 6Lepetit H, Eddahibi S, Fade1 E, et al. Sm Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension. Eur Respir J, 2005,25 (5) :834-842.
  • 7Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med, 2004,351 (16) : 1655-1665.
  • 8Takahashi H, Goto N, Kojima Y, et al. Downregulation of type II bone morphogentic protein receport in hypoxic pulmonary hypertension. Am J Physiol Lung Cell M01 Physiol, 2006,290(3 ) : L450-458.
  • 9Chen L, Xiao J, Li Y, et al. Ang-(1-7) might prevent the development of monocrotaline induced pulmonary arterial hypertension in rats. Eur Rev Med Pharmacol Sci, 2011,15 ( 1 ) : 1 - 7.
  • 10Molteni A, Wmxt WF, Ts'ao CH, et al. Monocrotaline-induced pulmonary endothelial dysfunction in rats. Proc Soc Exp Biol Med, 1984,176( 1 ) :88-94.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部